Lemaitre Vascular (LMAT) Net Margin (2010 - 2026)

Lemaitre Vascular (LMAT) has 17 years of Net Margin data on file, last reported at 23.56% in Q1 2026.

• On a quarterly basis, Net Margin rose 517.0% year-over-year to 23.56% in Q1 2026; TTM through Mar 2026 was 25.25%, a 38.0% decrease from a year earlier, with the FY2025 full-year figure at 24.06%, down 181.0% from the prior year.
• Net Margin for Q1 2026 stood at 23.56%, down from 27.76% in the prior quarter.
• Over the last five years, Net Margin for LMAT reached as high as 43.11% in Q4 2024 and fell as low as 8.35% in Q2 2022.
• Historically, Net Margin has averaged 19.6% across 5 years, with a median of 18.39% in 2025.
• Across the five-year window, Net Margin surged 2580 bps in 2024 and sank 1535 bps in 2025, its largest moves.
• Year by year, Net Margin stood at 10.77% in 2022, then soared by 61 bps to 17.32% in 2023, then soared by 149 bps to 43.11% in 2024, then plunged by 36 bps to 27.76% in 2025, then decreased by 15 bps to 23.56% in 2026.
• Per Business Quant data, the three most recent Net Margin figures were 23.56% in Q1 2026, 27.76% in Q4 2025, and 28.44% in Q3 2025.